Gladstone Investment Corp. Names New Director After Officer Departure
Gladstone Investment Corporation disclosed the election of a new independent director and the simultaneous departure of an existing board member. The change alters the company's board composition and triggers updated disclosures to investors and regulators within standard SEC timeframes.
tfipost.comGladstone Investment Corporation reported the election of Michael J. Sesser as a new independent director and the departure of another board member, according to an 8-K filed with the SEC on June 2, 2026.
The filing, submitted under Items 5.02, 7.01 and 9.01, affects the 11-member business development company board that oversees a portfolio of more than 20 middle-market companies. Gladstone Investment Corporation, with a market focus on debt and equity investments in lower middle market businesses, must now operate with its revised board structure for all future governance and investment decisions.
The board change took effect immediately upon the June 2, 2026 filing. Prior to the update the board included the departing director; the new state reflects Sesser's addition and the other director's exit with no cause cited in the document. The company did not report any simultaneous changes to its executive officer roster of principal officers.
Downstream, the company must incorporate the new board composition into its next proxy statement and any subsequent Form 10-Q or 10-K filings that require director listings. Regulation FD Item 7.01 disclosures in the same 8-K require the company to ensure all material information about the board change reaches the market uniformly.
Gladstone Investment Corporation will also need to update its director and officer questionnaires, committee assignments and any internal compliance policies that reference specific board members before the next annual shareholder meeting.
This marks the latest board-level change for Gladstone Investment Corporation, a publicly traded business development company that has periodically refreshed independent director seats to maintain compliance with Nasdaq governance rules and the Investment Company Act of 1940. The filing constitutes the official record and requires no further immediate regulatory approval.
Coverage spread
Substrate’s article above is written from the primary record. Below: how mainstream outlets reported the same event.
No mainstream coverage of this story has surfaced yet.
Transparency
Reported by a single outlet. This score reflects source tier and factual specificity — corroboration is limited with one source.
Related Stories
thehindu.comU.S. Strikes Botswana-Flagged Tanker in International Waters; Iran Blockade in Effect
A U.S. aircraft fired an AGM-114 Hellfire missile into the engine room of the M/T Lexie on Tuesday, disabling the unladen vessel as it headed toward Kharg Island. The strike followed repeated ignored warnings over 24 hours.
prnewswire.comFed Chairman Names Two Outside Advisers During Transition
Federal Reserve Chairman Kevin Warsh appointed two interim advisers shortly after taking the post. One previously contributed to a conservative plan calling for major changes at the central bank.
insidermonkey.comForte Biosciences Accepts Resignation of Director David Veitch
Forte Biosciences disclosed the resignation of independent director David Veitch from its board effective June 1 2026. The departure reduces the company's board size and triggers standard SEC and Nasdaq disclosure obligations for director changes at the clinical-stage biopharmace…